SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001078782-17-000216
Filing Date
2017-02-15
Accepted
2017-02-15 19:20:00
Documents
1
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 6790
  Complete submission text file 0001078782-17-000216.txt   8321
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Issuer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 EAST 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 855-232-9953
Anastassov George (Reporting) CIK: 0001604392 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-54296 | Film No.: 17616095